Verseon Acquires Edammo

October 18, 2022

Verseon International Corporation, a Fremont, California–based drug-discovery company, has acquired Edammo, Inc. to integrate Edammo's Extreme AutoML technology into Verseon's physics-augmented AI drug-discovery platform. The acquisition is intended to strengthen Verseon's machine‑learning capabilities for small, sparse life‑sciences datasets and accelerate drug candidate discovery.

Buyers
Verseon International Corporation
Targets
Edammo, Inc.
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.